US$ 28.39
how big is the glp-1 market Drugs Size to Hit USD 132.79 Bn by 2035 Market Overview: GLP-1 Agonists and
Description
Blunted GLP-1 after meals compared to controls has been well documented in weight suppressed bulimia nervosa patients for the last 15 years

Abstract The glucagon-like peptide-1 receptor (GLP-1R) is a class B G protein-coupled receptor and mainstay therapeutic target for the treatment of type 2 diabetes and obesity

Effect of liraglutide 3.0 mg treatment on weight reduction in obese antipsychotic-treated patients

Kosiborod MN, Abildstrom SZ, Borlaug BA, et al

This dual action not only stabilizes blood sugar levels but also reduces hunger signals, contributing to weight loss and better metabolic health
